SCHEMBL6426

SCHEMBL6426

CC(C)(C)OC(=O)NN(Cc1ccc(-c2cnccn2)cc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)C(F)(F)F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGT1A1 P22309 3/20 0.56
MLNR O43193 1/20 0.56
NR1I2 O75469 1/20 0.56
SLCO2B1 O94956 1/20 0.56
ABCB11 O95342 1/20 0.56
ABCB1 P08183 1/20 0.56
CCKAR P32238 1/20 0.56
OPRK1 P41145 1/20 0.56
GHSR Q92847 1/20 0.56
SLCO1B3 Q9NPD5 1/20 0.56
ABCG2 Q9UNQ0 1/20 0.56
SLCO1B1 Q9Y6L6 1/20 0.56
PSEN1 P49768 11/20 0.42
PSEN2 P49810 11/20 0.42
APH1B Q8WW43 11/20 0.42
NCSTN Q92542 11/20 0.42
APH1A Q96BI3 11/20 0.42
PSENEN Q9NZ42 11/20 0.42
KCNH2 Q12809 1/20 0.42
KLK5 Q9Y337 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6157500 1.00 UGT1A1 (0.56) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6157358 0.91 UGT1A1 (0.67) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6789 0.91 UGT1A1 (0.67) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL7548073 0.88 MLNR (0.52) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6443284 0.87 PSEN1 (0.52) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6443277 0.87 PSEN1 (0.52) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL7682 0.87 UGT1A1 (0.65) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6156299 0.87 UGT1A1 (0.65) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6157364 0.86 UGT1A1 (0.51) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6184 0.86 UGT1A1 (0.51) UGT1A1MLNRNR1I2SLCO2B1ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0900210-B1 ANTIVIRALLY ACTIVE HETEROCYCLIC AZAHEXANE DERIVATIVES NOVARTIS AG (CH) 2005-02-09 EP disclosed
US-6300519-B1 REACTING HYDRAZINE DERIVATIVE WITH EPOXIDE COMPOUND NOVARTIS FINANCE CORPORATION 2001-10-09 US disclosed
US-6166004-A Combinations of HIV protease inhibitors with reverse transcriptase inhibitors NOVARTIS FINANCE CORPORATION (US) 2000-12-26 US disclosed
US-6110946-A AN ENZYME INHIBITORS OF RETROVIRAL ASPARTATE PROTEASE FOR THE TREATMENT OF AIDS NOVARTIS FINANCE CORPORATION (US) 2000-08-29 US disclosed
EP-0900210-A1 ANTIVIRALLY ACTIVE HETEROCYCLIC AZAHEXANE DERIVATIVES Novartis AG (CH) 1999-03-10 EP disclosed
US-5849911-A Antivirally active heterocyclic azahexane derivatives NOVARTIS FINANCE CORPORATION (US) 1998-12-15 US disclosed
WO-1997040029-A1 ANTIVIRALLY ACTIVE HETEROCYCLIC AZAHEXANE DERIVATIVES NOVARTIS AG (CH) 1997-10-30 WO disclosed